发明名称 PYRAZOLE DERIVATIVE
摘要 PROBLEM TO BE SOLVED: To obtain a new pyrazole derivative having an excellent Ca2+ release activated Ca2+ channel(CRACC) inhibiting action and useful for prevention or treatment of inflammatory diseases, allergic diseases, or the like, in which CRACC participates. SOLUTION: This pyrazole derivative is represented by formula I [D is a pyrazolyl which may be substituted by a substituent group such as a lower alkyl, a lower alkenyl or a lower alkynyl; B is a divalent group of monocyclic aromatic hetero ring which may be substituted by phyenylene, or the like; X is NR1CO (R1 is H, OH, a lower alkyl, or the like), or the like; Y is a bond, CO or the like; A is a phenyl having at least one substituent group such as OH or the like], e.g. 4'-[3,5-bis(trifluoromethyl)1H-pyrazol-1-yl]-2,1,3- benzooxadiazol-5-carboxanilide. The compound of formula I can be obtained by subjecting, e.g. an amine derivative of formula II to amidation reaction with a carboxylic acid derivative of formula III.
申请公布号 JP2000256358(A) 申请公布日期 2000.09.19
申请号 JP19990062900 申请日期 1999.03.10
申请人 YAMANOUCHI PHARMACEUT CO LTD 发明人 KUBOTA KOICHI;YOSHIMURA NORIKO;OKAMOTO YOSHINORI;YONETOKU YASUHIRO;NAITO MAKOTO;ISHIKAWA ATSUSHI;TAKEUCHI MAKOTO
分类号 C07D231/12;A61K31/00;A61K31/415;A61K31/4155;A61K31/4164;A61K31/4184;A61K31/42;A61K31/422;A61K31/425;A61K31/427;A61K31/435;A61K31/4353;A61K31/437;A61K31/4375;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4439;A61K31/445;A61K31/4453;A61K31/4465;A61K31/4523;A61K31/4545;A61K31/47;A61K31/4709;A61K31/472;A61K31/4725;A61K31/495;A61K31/4965;A61K31/497;A61K31/4985;A61K31/505;A61K31/506;A61K31/535;A61K31/5375;A61K31/5377;A61K31/54;A61K31/541;A61K31/55;A61K31/551;A61K31/5513;A61P43/00;C07D231/16;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/04;(IPC1-7):C07D413/12 主分类号 C07D231/12
代理机构 代理人
主权项
地址